Transluminal balloon angioplasty, stents, and atherectomy.
Arterial bypass grafting for occlusive disease is still considered the gold standard in the treatment of arterial occlusive disease. However, less invasive methods are available for select patients. Percutaneous balloon angioplasty has been shown to be effective in focal iliac artery stenosis, with patency rates of 50% to 90% at 5 years. Patency rates for femoropopliteal lesions are generally less than 50% at 2 years. Complications seen with balloon angioplasty often can be treated with arterial stents. Stents can be categorized into balloon-expandable, which provide a rigid scaffold to support the artery, self-expanding, which exert radial force to resist external compression, and thermal expanding stents, which allow for the use of a smaller introducer sheath. Another treatment option is atherectomy, in which the offending lesion is removed instead of fracturing and dilating the lumen. Although overall initial results of atherectomy have not been favorable, short lesions with eccentric atheroma or intimal hyperplasia, such as those seen in dialysis access fistulas or vein graft stenoses, may respond well.
Ahn
S S
SS
Department of Surgery, UCLA School of Medicine 90095, USA.
Obrand
D I
DI
Moore
W S
WS
D000800:Angioplasty, Balloon / Q000295:instrumentation / Q000379:methods*; D001157:Arterial Occlusive Diseases / Q000628:therapy*; D017073:Atherectomy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D002986:Clinical Trials as Topic; D000075202:Contraindications; D006801:Humans; D011379:Prognosis; D015607:Stents / Q000009:adverse effects